SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001193125-15-300256
Filing Date
2015-08-24
Accepted
2015-08-24 16:26:59
Documents
14

Document Format Files

Seq Description Document Type Size
1 FORM F-1 (AMENDMENT NO. 2) d912889df1a.htm F-1/A 2639563
2 EX-1.1 d912889dex11.htm EX-1.1 235937
3 EX-3.1 d912889dex31.htm EX-3.1 67709
4 EX-4.4 d912889dex44.htm EX-4.4 157973
5 EX-10.2 d912889dex102.htm EX-10.2 87321
6 EX-10.6 d912889dex106.htm EX-10.6 50540
7 EX-10.11 d912889dex1011.htm EX-10.11 607361
8 EX-23.1 d912889dex231.htm EX-23.1 1413
9 GRAPHIC g912889g32b53.jpg GRAPHIC 51094
10 GRAPHIC g912889g47m42.jpg GRAPHIC 63495
11 GRAPHIC g912889g52e70.jpg GRAPHIC 117011
12 GRAPHIC g912889g59a54.jpg GRAPHIC 50769
13 GRAPHIC g912889g67a59.jpg GRAPHIC 36576
14 GRAPHIC g912889g94d16.jpg GRAPHIC 116569
  Complete submission text file 0001193125-15-300256.txt   4443482
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-205073 | Film No.: 151071276
SIC: 2834 Pharmaceutical Preparations